精鍛科技(300258.SZ):輕量化項目目前正在建設中,預計23年四季度形成產能
格隆匯2月14日丨精鍛科技(300258.SZ)於2023年2月14日下午14:00-16:00通過“價值在線”平台,採用網絡遠程的方式路演稱,公司輕量化項目目前正在建設中,預計23年四季度形成產能。公司輕量化項目產品主要面向傳統豪華品牌及中高端造車新勢力等企業,目前公司正在與多個目標客户項目交流中,預期2024年會形成量產銷售。
輕量化部件的應用有利於減輕整車重量,減少能耗,增強車輛控制穩定性和安全性,新能源車對減重要求更高,輕量化技術的應用是汽車行業未來發展重要趨勢之一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.